In this study, we identified a BCL2 family member, BCL2A1, as an inducible gene through genome-wide transcriptome profiling using the comparison of ovarian cancer cells treated with hypoxia vis-à-vis normoxia. This evidence concerns the gene BCL2 and ovarian cancer.